2 Apr 2024 • A recent study among COPD patients unveiled a worrying pattern: a decline in BMI following diagnosis was linked to a dose-dependent escalation in the risk of all-cause mortality.

• Notably, a decrease in BMI by more than 5% post-diagnosis is linked with a 70% increased risk of all-cause mortality, particularly pronounced in underweight patients, while an increase in BMI over 5% raises mortality risk by 13%.

These findings underscored the importance of monitoring weight fluctuations, especially in underweight individuals, as they face heightened mortality risk.

Source: Respiratory Research | Read full story